Semler Scientific (OTCMKTS:SMLR – Get Ranking) posted its quarterly earnings effects on Monday. The health care products company reported $.41 EPS for the quarter, lacking the consensus estimate of $.48 by ($.07), MarketWatch Earnings reports. Semler Scientific experienced a return on fairness of 44.76% and a web margin of 32.48%.
OTCMKTS SMLR opened at $47.34 on Tuesday. Semler Scientific has a fifty-two 7 days very low of $41.53 and a fifty-two 7 days large of $153.21. The stock’s fifty day shifting regular is $50.02 and its two-hundred day shifting common is $79.62. The business has a current market capitalization of $320.02 million, a P/E ratio of 20.26 and a beta of .90.
SMLR has been the subject matter of a number of research reviews. Colliers Securities reissued a “buy” rating on shares of Semler Scientific in a study note on Tuesday, March 22nd. Zacks Expense Investigation upgraded shares of Semler Scientific from a “strong sell” score to a “hold” ranking in a study be aware on Thursday, March 24th. Lake Avenue Money dropped their cost concentrate on on shares of Semler Scientific from $175.00 to $100.00 in a analysis take note on Tuesday, March 1st. TheStreet lower shares of Semler Scientific from a “b-” ranking to a “c” score in a investigate take note on Thursday, March 3rd. Lastly, B. Riley diminished their value concentrate on on shares of Semler Scientific from $145.00 to $70.00 and established a “buy” rating for the firm in a analysis report on Monday, March 7th. Just one expense analyst has rated the inventory with a maintain ranking and three have supplied a obtain ranking to the organization. According to MarketBeat.com, Semler Scientific presently has an average ranking of “Buy” and a consensus concentrate on price of $120.25.
In connected information, CEO Douglas Murphy-Chutorian marketed 2,000 shares of the stock in a transaction dated Monday, February 7th. The inventory was sold at an average cost of $78.73, for a overall transaction of $157,460.00. The transaction was disclosed in a document filed with the SEC, which is obtainable through this hyperlink. Company insiders personal 13.20% of the company’s stock.
A variety of institutional investors have not too long ago bought and sold shares of the business enterprise. BlackRock Inc. acquired a new stake in shares of Semler Scientific in the 4th quarter valued at around $5,795,000. The Manufacturers Life Insurance plan Company grew its position in shares of Semler Scientific by 206.7% in the fourth quarter. The Suppliers Existence Insurance policy Enterprise now owns 61,335 shares of the professional medical products provider’s inventory valued at $5,621,000 following acquiring an added 41,335 shares during the time period. Geode Cash Management LLC bought a new stake in shares of Semler Scientific in the fourth quarter valued at $4,247,000. Charles Schwab Financial investment Administration Inc. purchased a new stake in shares of Semler Scientific in the fourth quarter valued at $2,189,000. Eventually, Susquehanna Intercontinental Team LLP acquired a new position in Semler Scientific in the fourth quarter valued at $1,659,000. 44.69% of the stock is owned by institutional buyers.
Semler Scientific Organization Profile (Get Ranking)
Semler Scientific, Inc presents know-how alternatives to increase the clinical performance and efficiency of health care suppliers in the United States. The company’s products and solutions include things like QuantaFlo, a 4-moment in-office environment blood movement exam that enables healthcare suppliers to use blood movement measurements as portion of their exams of a patient’s vascular situation.
Further more Looking through
Want A lot more Great Investing Thoughts?
Acquire News & Ratings for Semler Scientific Daily – Enter your electronic mail handle below to obtain a concise each day summary of the hottest news and analysts’ ratings for Semler Scientific and linked organizations with MarketBeat.com’s Free of charge day by day e mail e-newsletter.